Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Shareholder Letter
Actually, PDS licensing revenues for the last quarter were $19.433M.  Revenues for the last SIX months were $20.933M.
Share
New Message
Please login to post a reply